Lotus Eye Hospital and Institute Limited

HealthcareHealthcareHealthcare ServicesHospital

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹122.04
Market cap
254 Cr
Stock P/E
3726.8
P/B
4.19
Dividend yield
0.0%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2020Mar 2025Jun 2025Sept 2025
Sales7 Cr12 Cr14 Cr13 Cr
Operating expenses (approx.)7 Cr11 Cr12 Cr12 Cr
EBITDA0.66 Cr0.35 Cr2 Cr1 Cr
OPM %9.2%3.1%12.3%8.0%
Other income0.22 Cr0.51 Cr0.19 Cr0.27 Cr
Interest0.02 Cr0.09 Cr0.12 Cr0.12 Cr
Depreciation0.58 Cr-0.58 Cr0.82 Cr0.85 Cr
Profit before tax0.07 Cr0.84 Cr0.73 Cr0.07 Cr
Tax %-16.8%70.0%25.3%-58.6%
Net profit0.08 Cr0.25 Cr0.54 Cr0.12 Cr
EPS (₹)₹0.04₹0.12₹0.26₹0.06

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2025TTM
Sales50 CrSign in for TTM
Operating expenses (approx.)45 CrSign in for TTM
EBITDA5 CrSign in for TTM
OPM %9.6%Sign in for TTM
Other income1 CrSign in for TTM
Interest0.35 CrSign in for TTM
Depreciation3 CrSign in for TTM
Profit before tax1 CrSign in for TTM
Tax %46.5%Sign in for TTM
Net profit0.74 CrSign in for TTM
EPS (₹)₹0.36Sign in for TTM
Dividend payout %1.4%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2025
Equity capital21 Cr
Reserves39 Cr
Borrowings
Other liabilities10 Cr
Total liabilities70 Cr
Fixed assets (net)49 Cr
CWIP0.0000 Cr
Investments0.0000 Cr
Other assets12 Cr
Total assets70 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2025
Cash from operating activity5 Cr
Cash from investing-4 Cr
Cash from financing-2 Cr
Net cash flow-0.64 Cr
Free cash flow (OCF − Capex)0.12 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2025
ROCE %2.9%
ROE %1.2%
Debtor days
Inventory days169
Days payable
Cash conversion cycle169
Debt / equity
Current ratio1.56
Net debt / EBITDA-0.42

Compare with peers

Loading peers…